• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在用106Ru/106Rh眼科敷贴器治疗失败后的脉络膜恶性黑色素瘤的组织病理学研究。

Histopathology studies in human malignant melanomas of the choroid after unsuccessful treatment with 106Ru/106Rh ophthalmic applicators.

作者信息

Klaus H, Lommatzsch P K, Fuchs U

机构信息

Augenklinik Universität Leipzig, Federal Republic of Germany.

出版信息

Graefes Arch Clin Exp Ophthalmol. 1991;229(5):480-6. doi: 10.1007/BF00166314.

DOI:10.1007/BF00166314
PMID:1937083
Abstract

Choroidal malignant melanomas were examined after unsuccessful brachytherapy with 106Ru/106Rh ophthalmic plaques. The histologic findings were compared with those obtained in non-irradiated melanomas similar in size and location. Both groups revealed no significant clinical difference apart from the lower average age of the irradiated patients. Some of the histologic features (scar formation, changes in the distribution of cell types, rate of mitosis) represented reactions to irradiation. No single histologic feature was strongly correlated to the irradiated group. The phenomenon of radioinsensitivity observed in some malignant melanomas cannot be fully elucidated using conventional histologic methods.

摘要

对采用¹⁰⁶Ru/¹⁰⁶Rh眼用敷贴器进行近距离放射治疗失败后的脉络膜恶性黑色素瘤进行了检查。将组织学结果与在大小和位置相似的未照射黑色素瘤中获得的结果进行比较。除了接受照射患者的平均年龄较低外,两组在临床上没有显著差异。一些组织学特征(瘢痕形成、细胞类型分布变化、有丝分裂率)代表了对辐射的反应。没有单一的组织学特征与照射组有强烈关联。使用传统组织学方法无法完全阐明在一些恶性黑色素瘤中观察到的放射不敏感现象。

相似文献

1
Histopathology studies in human malignant melanomas of the choroid after unsuccessful treatment with 106Ru/106Rh ophthalmic applicators.在用106Ru/106Rh眼科敷贴器治疗失败后的脉络膜恶性黑色素瘤的组织病理学研究。
Graefes Arch Clin Exp Ophthalmol. 1991;229(5):480-6. doi: 10.1007/BF00166314.
2
Fluorescein angiography in the follow-up study of choroidal melanoma after 106Ru/106Rh plaque therapy.106Ru/106Rh敷贴治疗后脉络膜黑色素瘤随访研究中的荧光素血管造影
Retina. 1987 Fall;7(3):148-55. doi: 10.1097/00006982-198700730-00003.
3
106Ru/106Rh plaque radiotherapy for malignant melanomas of the choroid. With follow-up results more than 5 years.
Doc Ophthalmol. 1988 Mar-Apr;68(3-4):225-38. doi: 10.1007/BF00156429.
4
[Optimization of irradiation time in the treatment of malignant melanoma of the choroid with beta applicators (106Ru/106Rh)].[使用β敷贴器(106Ru/106Rh)治疗脉络膜恶性黑色素瘤时照射时间的优化]
Klin Monbl Augenheilkd. 1986 Aug;189(2):133-40. doi: 10.1055/s-2008-1050770.
5
Treatment of choroidal melanomas with 106Ru/106Rh beta-ray applicators.用106Ru/106Rhβ射线敷贴器治疗脉络膜黑色素瘤。
Trans Ophthalmol Soc U K (1962). 1977 Sep;97(3):428-9.
6
[Echocardiography findings before and following beta-irradiation (106Ru/106Rh) of choroid melanoma].
Klin Monbl Augenheilkd. 1987 Jan;190(1):17-20. doi: 10.1055/s-2008-1050320.
7
[Radiation retinopathy following treatment of choroid melanomas with 106Ru/106Rh applicators].[使用106Ru/106Rh敷贴器治疗脉络膜黑色素瘤后的放射性视网膜病变]
Fortschr Ophthalmol. 1983;80(5):418-21.
8
Techniques and results of 106Ru/106Rh radiation of choroidal tumours.脉络膜肿瘤的106钌/106铑放射治疗技术与结果
Trans Ophthalmol Soc U K (1962). 1983;103 ( Pt 1):72-7.
9
Treatment of choroidal melanomas with 106Ru/106Rh beta-ray applicators.
Surv Ophthalmol. 1974 Sep-Oct;19(2):85-100.
10
Radiation effects on the optic nerve observed after brachytherapy of choroidal melanomas with 106Ru/106Rh plaques.用106Ru/106Rh敷贴器对脉络膜黑色素瘤进行近距离放射治疗后观察到的对视神经的辐射效应。
Graefes Arch Clin Exp Ophthalmol. 1994 Aug;232(8):482-7. doi: 10.1007/BF00195358.

引用本文的文献

1
Pathologic Features of Tumor Activity and Stability in Uveal Melanoma Specimens after Fractionated CyberKnife Radiosurgery.分割式射波刀放射外科治疗后葡萄膜黑色素瘤标本中肿瘤活性和稳定性的病理特征
Pathol Oncol Res. 2019 Apr;25(2):731-740. doi: 10.1007/s12253-018-00565-1. Epub 2019 Jan 7.
2
[High-dose 106Ruthenium plaque brachytherapy for posterior uveal melanoma. A clinico-pathologic study].
Ophthalmologe. 2007 Feb;104(2):149-57. doi: 10.1007/s00347-006-1451-3.
3
18 years' experience with high dose rate strontium-90 brachytherapy of small to medium sized posterior uveal melanoma.18年高剂量率锶-90近距离放射治疗中小型后葡萄膜黑色素瘤的经验。

本文引用的文献

1
Malignant melanoma of the choroid treated with radioactive applicators.用放射性敷贴器治疗脉络膜恶性黑色素瘤。
Trans Ophthalmol Soc U K (1962). 1959;79:373-92.
2
Focal ionizing radiation of the posterior ocular segment.
Am J Ophthalmol. 1960 Dec;50:1215-25. doi: 10.1016/0002-9394(60)91012-6.
3
Irradiation of the posterior ocular segment with radioactive yttrium.用放射性钇对眼后段进行照射。
Am J Ophthalmol. 1956 Jul;42(1):85-8. doi: 10.1016/0002-9394(56)90013-7.
Br J Ophthalmol. 2005 Oct;89(10):1306-10. doi: 10.1136/bjo.2005.068460.
4
Vascular perfusion of choroidal melanoma by 3.0 tesla magnetic resonance imaging.通过3.0特斯拉磁共振成像对脉络膜黑色素瘤进行血管灌注成像
Trans Am Ophthalmol Soc. 2004;102:209-15; discussion 215-7.
5
Uveal melanoma: updated considerations on current management modalities.葡萄膜黑色素瘤:当前治疗方式的最新考量
Int Ophthalmol. 1995;19(4):203-9. doi: 10.1007/BF00132688.
4
Histopathology of enucleated intraocular melanomas irradiated with cobalt and ruthenium plaques.
Acta Ophthalmol (Copenh). 1988 Jun;66(3):255-66. doi: 10.1111/j.1755-3768.1988.tb04594.x.
5
Pattern of mortality in choroidal malignant melanoma.脉络膜恶性黑色素瘤的死亡率模式
Br J Ophthalmol. 1980 Aug;64(8):565-75. doi: 10.1136/bjo.64.8.565.
6
Irradiation of choroidal melanoma with iodine 125 ophthalmic plaque.用碘125眼贴照射脉络膜黑色素瘤。
Arch Ophthalmol. 1980 Aug;98(8):1453-7. doi: 10.1001/archopht.1980.01020040305019.
7
Helium ion therapy for choroidal melanoma.
Arch Ophthalmol. 1982 Jun;100(6):935-8. doi: 10.1001/archopht.1982.01030030943008.
8
Failure of choroidal melanoma to respond to helium ion therapy.
Arch Ophthalmol. 1983 Feb;101(2):236-41. doi: 10.1001/archopht.1983.01040010238011.
9
Helium ion therapy for choroidal melanoma.
Ophthalmology. 1983 Oct;90(10):1219-25. doi: 10.1016/s0161-6420(83)34405-5.
10
A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma.
Arch Ophthalmol. 1983 Dec;101(12):1894-9. doi: 10.1001/archopht.1983.01040020896012.